Literature DB >> 6408234

Carnitine deficiency with valproate therapy.

D A Stumpf, W D Parker, R Haas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6408234     DOI： 10.1016/s0022-3476(83)80831-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

Review 1.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 2.  Structural understanding of T cell receptor triggering.

Authors:  Xinyi Xu; Hua Li; Chenqi Xu
Journal:  Cell Mol Immunol       Date:  2020-02-11       Impact factor: 11.530

Review 3.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

4.  TCR-pMHC bond conformation controls TCR ligand discrimination.

Authors:  Dibyendu K Sasmal; Wei Feng; Sobhan Roy; Peter Leung; Yanran He; Chufan Cai; Guoshuai Cao; Huada Lian; Jian Qin; Enfu Hui; Hans Schreiber; Erin J Adams; Jun Huang
Journal:  Cell Mol Immunol       Date:  2019-09-17       Impact factor: 11.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.